Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,922,210
-$259,465 QoQ
Shares Held
79,826
+2.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#986
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROWLANDMILLER & PARTNERS.ADV holds $61,867,127 across 7 Drug Manufacturers - General names. PFE ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,075 | $18,081,408 | |
| 2 | JNJ |
Johnson & Johnson
|
64,152 | $16,292,683 | |
| 3 | ABBV |
AbbVie Inc.
|
43,246 | $10,882,423 | |
| 4 | AMGN |
Amgen Inc
|
14,748 | $5,340,545 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,007 | $4,755,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
36,350 | $4,592,459 | |
| 7 | PFE |
Pfizer Inc
This page
|
79,826 | $1,922,210 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,922,210 | 79,826 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,181,675 | 77,695 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $2,035,276 | 81,738 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,092,417 | 82,120 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $1,944,460 | 80,217 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $2,037,183 | 80,394 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,197,824 | 82,843 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,434,114 | 84,109 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,328,131 | 83,207 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,188,587 | 78,868 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $1,991,289 | 69,166 | Shares | Sole | 2024-01-03 | |
| 2023-09-30 | $2,353,112 | 70,941 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,648,662 | 72,210 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,015,732 | 73,915 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $3,770,854 | 73,592 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $3,236,489 | 73,960 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $3,874,209 | 73,893 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,823,680 | 73,859 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $4,387,178 | 74,296 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,654,792 | 61,725 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,851,396 | 72,814 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,451,502 | 67,665 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,370,343 | 64,394 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,256,644 | 61,489 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,018,409 | 61,725 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,006,998 | 61,489 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||